Breaking News, Collaborations & Alliances

Cryoport Enters Strategic Relationship with BioLife Plasma Services

The companies aim to establish a standardized, integrated apheresis collection, processing, and distribution solution for cellular therapies.

Author Image

By: Charlie Sternberg

Associate Editor

Cryoport Inc., a leader in temperature-controlled supply chain solutions for the life sciences industry, has entered into a strategic relationship with BioLife Plasma Services, part of the global biopharmaceutical company Takeda, intended to provide consistent, high-quality cellular starting material for use in the manufacture of life-saving cellular therapies.   By bringing together BioLife Plasma Services’ proficiency in apheresis collection and their donation center infrastructure wit...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters